GLX Analytix
PrivateLast Round
VC Round
Oct 29, 2024
Total Funding Raised
$678,253
Company Overview
GLX Analytix is a biotechnology company that operates a personalized medicine platform utilizing vascular biology and artificial intelligence to advance diagnostics and monitoring for chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GLX Analytix Comparables
Compare GLX Analytix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Progentec Diagnostics | 78% | |
| Moleculera Biosciences | 76% | |
| Octave Bioscience | 72% |
GLX Analytix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 29, 2024 | ||||
| Grant | Jul 5, 2024 | ||||
| Seed | Jun 14, 2022 | ||||
| Grant | Feb 1, 2020 |
Key People
Founding team and executive leadership
GLX Analytix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Investment Group | Seed |
| The Export and Investment Fund of Denmark | VC Round, Seed |
| DigitalDx Ventures | Seed |
| DigitalDx Ventures | VC Round, Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2024
$598K grant received from Alzheimer's Drug Discovery Foundation.
- Jun 14, 2022
Led by DigitalDx Ventures with participation from Labcorp.
GLX Analytix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GLX Analytix's valuation, stock price, and market status.
Is GLX Analytix a public or private company?
GLX Analytix is a private company.
What is the current stock price of GLX Analytix?
GLX Analytix is a private company with no public stock price. No recent secondary market data is available.
How much is GLX Analytix worth (valuation)?
Valuation information for GLX Analytix is not publicly available.
Can I buy GLX Analytix stock?
GLX Analytix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GLX Analytix's last funding round?
GLX Analytix's most recent funding round was VC Round on October 29, 2024.
Who are the main investors in GLX Analytix?
Key investors in GLX Analytix include DigitalDx Ventures.
Will GLX Analytix IPO soon?
No public IPO plans have been announced for GLX Analytix.
How can I track GLX Analytix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GLX Analytix's secondary market activity and sign up for updates.